Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pierconti

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Human Pathology|September 28, 2021
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samplesFrancesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Cancers|August 14, 2025
L1CAM Reliably Distinguishes Low-Grade Oncocytic Tumor from Other Eosinophilic Renal Neoplasms: A Multicenter Immunohistochemical Study with Diagnostic ImplicationsLuciana Scuccimarri, Antonio d'Amati, Francesco Pierconti, et al.
Virchows Archiv : an International Journal of Pathology|February 9, 2020
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Cancers|September 9, 2022
Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based ImagingValerio Di Paola, Giorgio Mazzotta, Vincenza Pignatelli, et al.
Journal of Clinical Medicine|December 9, 2023
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological CentreFilippo Gavi, Barbara Fiori, Carlo Gandi, et al.
American Journal of Clinical Pathology|August 23, 2012
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastomaTonia Cenci, Maurizio Martini, Nicola Montano, et al.
Scientific Reports|December 7, 2016
MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer CellsAurora Aiello, Lorenza Bacci, Agnese Re, et al.
Cancer Cytopathology|October 20, 2022
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk groupFrancesco Pierconti, Esther Diana Rossi, Tonia Cenci, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Human Pathology|September 28, 2021
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samplesFrancesco Pierconti, Maurizio Martini, Vincenzo Fiorentino, et al.
Urologic Oncology|December 14, 2021
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinomaFrancesco Pierconti, Maurizio Martini, Tonia Cenci, et al.
Cancers|August 14, 2025
L1CAM Reliably Distinguishes Low-Grade Oncocytic Tumor from Other Eosinophilic Renal Neoplasms: A Multicenter Immunohistochemical Study with Diagnostic ImplicationsLuciana Scuccimarri, Antonio d'Amati, Francesco Pierconti, et al.
Virchows Archiv : an International Journal of Pathology|February 9, 2020
PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2020
Correction to: PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG respondersFrancesco Pierconti, Maria Rosaria Raspollini, Maurizio Martini, et al.
Cancers|September 9, 2022
Beyond N Staging in Breast Cancer: Importance of MRI and Ultrasound-based ImagingValerio Di Paola, Giorgio Mazzotta, Vincenza Pignatelli, et al.
Journal of Clinical Medicine|December 9, 2023
Prevalence and Antimicrobial Resistance Patterns of Hospital Acquired Infections through the COVID-19 Pandemic: Real-Word Data from a Tertiary Urological CentreFilippo Gavi, Barbara Fiori, Carlo Gandi, et al.
American Journal of Clinical Pathology|August 23, 2012
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastomaTonia Cenci, Maurizio Martini, Nicola Montano, et al.
Scientific Reports|December 7, 2016
MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer CellsAurora Aiello, Lorenza Bacci, Agnese Re, et al.
Cancer Cytopathology|October 20, 2022
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk groupFrancesco Pierconti, Esther Diana Rossi, Tonia Cenci, et al.
Pageof 12